Sep 9, 2021 | News
On September 14, 2021, Denovicon Therapeutics Founder & CEO, Scott Bembenek, will present on Denovicon’s ‘AI–Molecular Modeling Platform for Enhanced Small-Molecule Drug Discovery’ at the Biovia User Group Meeting 2021.
Mar 13, 2021 | News
On March 15, 2021, Denovicon Therapeutics Founder & CEO, Scott Bembenek, talked on ‘Combining Machine Learning and Molecular Modeling for Enhanced Active Learning in Small-Molecule Drug Design’ at the AI in Drug Discovery 2021.
Nov 14, 2020 | News
On November 16, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, spoke at the Global Pharma R&D AI, Data Science and Informatics Summit (PRADI 2020) on ‘Combining Machine Learning and Molecular Modeling for Enhanced Active Learning in...
Oct 8, 2020 | News
On November 5, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, took part in the Lab of the Future panel entitled ‘Strategies for Accelerating Drug Discovery with AI.’
Jul 15, 2020 | News
On July 14, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, shared some of his experiences and insights from his scientific and entrepreneurial journeys (thus far) with Rady and UCSD students at Rady’s Careers in Biotech Panel.
Jun 26, 2020 | News
As part of Denovicon Therapeutics’ commitment to COVID-19, we tasked our novel molecular modeling-artificial intelligence (AI) hybrid computational platform to find potential therapies from over 13,000 FDA-approved drugs and clinical candidates. The molecular modeling...
